Callan Family Office’s Zoetis ZTS Stock Holding History
Bought
Maintained
Sold
Other funds holding ZTS
Callan Family Office's ZTS Position: Q2 2026 in Review
Callan Family Office reduced its Zoetis (ZTS) stake by 42% in Q2 2026, selling an estimated $862K and leaving 12,528 shares worth $900K. The position accounts for 0.02% of the portfolio, ranked #625.
Callan Family Office first reported a position in ZTS in Q4 2024 and has held it in 7 quarters since. The position peaked at $2.71M in Q4 2025. 1,435 funds tracked by Wall St. Rank hold ZTS as of Q2 2026.
- Callan Family Office held 12,528 shares of Zoetis worth $900K as of Q2 2026.
- Callan Family Office sold 9,157 Zoetis shares in Q2 2026, an estimated $862K.
- Zoetis made up 0.02% of Callan Family Office's portfolio in Q2 2026, its #625 holding.
- Callan Family Office first reported a position in Zoetis in Q4 2024 and has held it in 7 quarters since.
- Callan Family Office's Zoetis position peaked at $2.71M in Q4 2025.
- 1,435 funds tracked by Wall St. Rank held Zoetis as of Q2 2026.
Based on Callan Family Office's 13F filing for Q2 2026, filed 11 Aug 2026.